{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:09:11Z","timestamp":1779008951760,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004390","name":"Ottawa Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","award":["15-24"],"award-info":[{"award-number":["15-24"]}],"id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.placenta.2026.01.016","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:12:41Z","timestamp":1770311561000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Placental anti-angiogenic and inflammatory markers and postpartum cardiovascular risk following preeclampsia"],"prefix":"10.1016","volume":"176","author":[{"given":"Erika Elizabeth","family":"Mery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrreya","family":"Sudade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goutham","family":"Vasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Benton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"El Demellawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Grynspan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-8152","authenticated-orcid":false,"given":"Shannon","family":"Bainbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2026.01.016_bib1","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.placenta.2026.01.016_bib2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.placenta.2026.01.016_bib3","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","article-title":"Global and regional causes of maternal deaths 2009\u201320: a WHO systematic analysis","volume":"13","author":"Cresswell","year":"2025","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.placenta.2026.01.016_bib4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2026.01.016_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.113.01513","article-title":"Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring","volume":"62","author":"Fraser","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.01.016_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11936-018-0653-8","article-title":"Hypertensive disorders of pregnancy and cardiovascular diseases: current knowledge and future directions","volume":"20","author":"Coutinho","year":"2018","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in Women\u20142011 update","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.01.016_bib8","first-page":"69","article-title":"Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis","volume":"23","author":"Palmer","year":"2017","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.placenta.2026.01.016_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jc.2007-1550","article-title":"Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies","volume":"93","author":"Gu","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.placenta.2026.01.016_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.placenta.2026.01.016_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.placenta.2026.01.016_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajog.2004.11.038","article-title":"Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia","volume":"193","author":"Powers","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2174\/15665240113139990058","article-title":"Membrane and soluble forms of endoglin in preeclampsia","volume":"13","author":"Oujo","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.116.07293","article-title":"Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia","volume":"68","author":"Leavey","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.01.016_bib17","doi-asserted-by":"crossref","first-page":"604.e1","DOI":"10.1016\/j.ajog.2018.09.036","article-title":"The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology","volume":"219","author":"Benton","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/uog.18959","article-title":"Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies","volume":"51","author":"Giannakou","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.placenta.2026.01.016_bib20","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1016\/j.ajog.2020.10.052","article-title":"Preeclampsia has two phenotypes which require different treatment strategies","volume":"226","author":"Masini","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"For the global pregnancy collaboration, subtypes of preeclampsia: Recognition and determining clinical usefulness","volume":"77","author":"Roberts","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.01.016_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2019.06.384","article-title":"Both \u201ccanonical\u201d and \u201cimmunological\u201d preeclampsia subtypes demonstrate changes in placental immune cell composition","volume":"83","author":"Leavey","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.01.016_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ogc.2019.10.001","article-title":"The placenta as a window to maternal vascular health","volume":"47","author":"Parks","year":"2020","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.placenta.2026.01.016_bib24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/jcm11061576","article-title":"Placental pathology as a tool to identify women for postpartum cardiovascular risk screening following preeclampsia: a preliminary investigation","volume":"11","author":"Benton","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2008.11.021","article-title":"Placental stress and pre-eclampsia: a revised view","volume":"30","author":"Redman","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.01.016_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2022.03.009","article-title":"Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological, and high-dimensional biology studies","volume":"125","author":"Than","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.01.016_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.121.18394","article-title":"Maternal vascular lesions in the placenta predict vascular impairments a decade after delivery","volume":"79","author":"Catov","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.01.016_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.whi.2010.05.004","article-title":"Pregnancy: a screening test for later life cardiovascular disease","volume":"20","author":"Roberts","year":"2010","journal-title":"Womens Health Issues"},{"issue":"11","key":"10.1016\/j.placenta.2026.01.016_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11906-015-0595-4","article-title":"Preeclampsia: syndrome or disease?","volume":"17","author":"Myatt","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.placenta.2026.01.016_bib30","doi-asserted-by":"crossref","first-page":"438.e1","DOI":"10.1016\/j.ajog.2013.12.001","article-title":"The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications","volume":"210","author":"Cusimano","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.placenta.2026.01.016_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/10935266231164446","article-title":"Synoptic reporting in clinical placental pathology: a preliminary investigation into report findings and interobserver agreement","volume":"26","author":"Dancey","year":"2023","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.placenta.2026.01.016_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.placenta.2026.01.016_bib34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1701-2163(16)35381-6","article-title":"Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia","volume":"34","author":"Smith","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.placenta.2026.01.016_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2023.102435","article-title":"Pregnancy-associated cardiovascular risks and postpartum care; an opportunity for interventions aiming at health preservation and disease prevention","volume":"92","author":"Wallin","year":"2024","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jogc.2018.10.024","article-title":"Cardiovascular risk assessment and Follow-Up of women after hypertensive disorders of pregnancy:a prospective cohort study","volume":"41","author":"Gladstone","year":"2019","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.placenta.2026.01.016_bib37","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2012.14312","article-title":"Lifetime risk and years lived free of total cardiovascular disease","volume":"308","author":"Wilkins","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.placenta.2026.01.016_bib38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.01.016_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4132\/jptm.2016.08.08","article-title":"Immunohistochemistry for pathologists: protocols, pitfalls, and tips","volume":"50","author":"Kim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.placenta.2026.01.016_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1517\/13543776.2011.577071","article-title":"Soluble fms-like tyrosine kinase-1 antibody for diagnosis purposes (WO2010075475)","volume":"21","author":"Boyaud","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.placenta.2026.01.016_bib41","doi-asserted-by":"crossref","DOI":"10.4172\/2469-9756.1000121","article-title":"Different pairs of monoclonal antibodies detect variable amounts of soluble endoglin in human blood plasma","volume":"2","author":"Smirnov","year":"2016","journal-title":"Immunochem Immunopathol"},{"key":"10.1016\/j.placenta.2026.01.016_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2026.01.016_bib43","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3465","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc"},{"key":"10.1016\/j.placenta.2026.01.016_bib44","first-page":"632","article-title":"Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis","volume":"46","author":"Schalekamp-Timmermans","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.placenta.2026.01.016_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preghy.2018.02.009","article-title":"The impact of female fetal sex on preeclampsia and the maternal immune milieu","volume":"12","author":"Taylor","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2026.01.016_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2016.01.006","article-title":"Human chorionic gonadotropin, fetal sex and risk of hypertensive disorders of pregnancy: a nested case-control study","volume":"6","author":"Zheng","year":"2016","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2026.01.016_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1471-0528.14163","article-title":"Fetal sex and maternal risk of pre-eclampsia\/eclampsia: a systematic review and meta-analysis","volume":"124","author":"Jaskolka","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2026.01.016_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2025.101262","article-title":"Association between fetal sex and preeclampsia: a case-control study","volume":"42","author":"Cordero-Franco","year":"2025","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.placenta.2026.01.016_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jpsychires.2010.10.008","article-title":"The role and interpretation of pilot studies in clinical research","volume":"45","author":"Leon","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.placenta.2026.01.016_bib61","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.fertnstert.2024.01.040","article-title":"A brief overview of pilot studies and their sample size justification","volume":"121","author":"Kunselman","year":"2024","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.placenta.2026.01.016_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.06.035","article-title":"Pre-Eclampsia New Emerging Team (PE-NET), A history of preeclampsia identifies women who have underlying cardiovascular risk factors","volume":"200","author":"Smith","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187923","article-title":"Breastfeeding and maternal cardiovascular risk factors and outcomes: a systematic review","volume":"12","author":"Nguyen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2026.01.016_bib51","first-page":"60","article-title":"Preeclampsia brings the risk of premature cardiovascular disease in women closer to that of men","volume":"36","author":"Langlois","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.placenta.2026.01.016_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/uog.17342","article-title":"Delivery of small-for-gestational-age neonate and association with early-onset impaired maternal endothelial function","volume":"49","author":"Hillman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.01.016_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10654-015-0067-9","article-title":"Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden","volume":"31","author":"DeRoo","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.placenta.2026.01.016_bib54","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/CIRCULATIONAHA.118.036632","article-title":"Placental growth factor as an indicator of maternal cardiovascular risk after pregnancy","volume":"139","author":"Benschop","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.01.016_bib55","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/HYPERTENSIONAHA.120.15830","article-title":"Angiogenic factors and long-term cardiovascular risk in women that developed preeclampsia during pregnancy","volume":"76","author":"Garrido-Gimenez","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.01.016_bib56","first-page":"407","article-title":"The importance of inflammatory and angiogenic markers in the evaluation of early cardiovascular disease risk in women with hypertensive disorders of pregnancy","volume":"10","author":"Maselien\u0117","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.placenta.2026.01.016_bib57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCRESAHA.124.325581","article-title":"Advances in our understanding of cardiovascular diseases after preeclampsia","volume":"136","author":"Countouris","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.placenta.2026.01.016_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/jwh.2015.5414","article-title":"Preeclampsia and vascular function: a window to future cardiovascular disease risk","volume":"25","author":"Enkhmaa","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.placenta.2026.01.016_bib59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ppe.13059","article-title":"Heterogeneity in the risk of cardiovascular disease mortality after the hypertensive disorders of pregnancy across mothers' lifetime reproductive history","volume":"38","author":"Wyatt","year":"2024","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.placenta.2026.01.016_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.placenta.2019.01.009","article-title":"A synoptic framework and future directions for placental pathology reporting","volume":"77","author":"Benton","year":"2019","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:29:42Z","timestamp":1779006582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400426000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"alternative-id":["S0143400426000287"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.01.016","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental anti-angiogenic and inflammatory markers and postpartum cardiovascular risk following preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}